Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PACT partner-treatment study for bacterial vaginosis in LGBTQIA+ couples
ACTRN12622001431718Phase 3Recruiting
- Sponsor
- Monash University
- Start
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of metronidazole and clindamycin in bacterial vaginosis (BV) (4 arms), sponsored by Monash University. Primary endpoints: Acceptability, tolerability and adherence to concurrent partner treatment and Effect of treatment strategies on genital microbiota. Started Jan 2024; status: recruiting.
02
Drugs
metronidazoleclindamycin
03
Conditions
bacterial vaginosis (BV)
Beyond the preview
Go deeper on ACTRN12622001431718.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12622001431718.